デフォルト表紙
市場調査レポート
商品コード
1355941

世界の特殊医薬品市場:考察と予測 (2029年まで)

Global Specialty Pharmaceutical Market Insights, Forecast to 2029

出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
世界の特殊医薬品市場:考察と予測 (2029年まで)
出版日: 2023年10月05日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、特殊医薬品 (Specialty Pharmaceutical) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の特殊医薬品の市場規模成長率:タイプ別, 2018 VS 2022 VS 2029
    • Antibody
    • Hormone
    • Growth Factors
    • Other
  • 市場:用途別
    • 世界の特殊医薬品の市場規模成長率:用途別, 2018 VS 2022 VS 2029
    • Tumor
    • Diabetes
    • Cardiovascular
    • Hemophilia
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の特殊医薬品の市場展望 (2018-2029)
  • 世界の特殊医薬品の市場成長トレンド:地域別
    • 特殊医薬品 市場規模:地域別: 2018 VS 2022 VS 2029
    • 特殊医薬品の市場規模実績:地域別 (2018-2023)
    • 特殊医薬品の市場規模予測:地域別 (2024-2029)
  • 特殊医薬品 市場動向
    • 特殊医薬品 業界動向
    • 特殊医薬品 市場の促進要因
    • 特殊医薬品 市場の課題
    • 特殊医薬品 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界規模の売上高 特殊医薬品 :競合別
    • 世界の特殊医薬品の収益:企業別 (2018-2023)
    • 世界の特殊医薬品の収益シェア:企業別 (2018-2023)
  • 世界の特殊医薬品の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 特殊医薬品, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の特殊医薬品 市場集中度
    • 世界の特殊医薬品 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: 特殊医薬品の収益 2022
  • 世界の主要企業 特殊医薬品 本社 および提供地域
  • 世界の主要企業 特殊医薬品, 製品およびアプリケーション
  • 世界の主要企業 特殊医薬品, 業界参入時期
  • M&A, 拡張計画

第4章 特殊医薬品 内訳データ:タイプ別

  • 世界の特殊医薬品の市場規模実績:タイプ別 (2018-2023)
  • 世界の特殊医薬品の市場規模予測:タイプ別 (2024-2029)

第5章 特殊医薬品 内訳データ:用途別

  • 世界の特殊医薬品の市場規模実績:用途別 (2018-2023)
  • 世界の特殊医薬品の市場規模予測:用途別 (2024-2029)

第6章 北米

  • 北米の特殊医薬品 市場規模 (2018-2029)
  • 北米の特殊医薬品 市場規模:タイプ別
    • 北米の特殊医薬品 市場規模:タイプ別 (2018-2023)
    • 北米の特殊医薬品 市場規模:タイプ別 (2024-2029)
    • 北米の特殊医薬品の市場シェア:タイプ別 (2018-2029)
  • 北米の特殊医薬品 市場規模:用途別
    • 北米の特殊医薬品 市場規模:用途別 (2018-2023)
    • 北米の特殊医薬品 市場規模:用途別 (2024-2029)
    • 北米の特殊医薬品の市場シェア:用途別 (2018-2029)
  • 北米の特殊医薬品 市場規模:国別
    • 北米の特殊医薬品 市場規模:国別: 2018 VS 2022 VS 2029
    • 北米の特殊医薬品 市場規模:国別 (2018-2023)
    • 北米の特殊医薬品 市場規模:国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の特殊医薬品 市場規模 (2018-2029)
  • 欧州の特殊医薬品 市場規模:タイプ別
    • 欧州の特殊医薬品 市場規模:タイプ別 (2018-2023)
    • 欧州の特殊医薬品 市場規模:タイプ別 (2024-2029)
    • 欧州の特殊医薬品の市場シェア:タイプ別 (2018-2029)
  • 欧州の特殊医薬品 市場規模:用途別
    • 欧州の特殊医薬品 市場規模:用途別 (2018-2023)
    • 欧州の特殊医薬品 市場規模:用途別 (2024-2029)
    • 欧州の特殊医薬品の市場シェア:用途別 (2018-2029)
  • 欧州の特殊医薬品 市場規模:国別
    • 欧州の特殊医薬品 市場規模:国別: 2018 VS 2022 VS 2029
    • 欧州の特殊医薬品 市場規模:国別 (2018-2023)
    • 欧州の特殊医薬品 市場規模:国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の特殊医薬品 市場規模 (2018-2029)
  • 中国の特殊医薬品 市場規模:タイプ別
    • 中国の特殊医薬品 市場規模:タイプ別 (2018-2023)
    • 中国の特殊医薬品 市場規模:タイプ別 (2024-2029)
    • 中国の特殊医薬品の市場シェア:タイプ別 (2018-2029)
  • 中国の特殊医薬品 市場規模:用途別
    • 中国の特殊医薬品 市場規模:用途別 (2018-2023)
    • 中国の特殊医薬品 市場規模:用途別 (2024-2029)
    • 中国の特殊医薬品の市場シェア:用途別 (2018-2029)

第9章 アジア(中国を除く)

  • アジア地域 特殊医薬品 市場規模 (2018-2029)
  • アジア地域 特殊医薬品 市場規模:タイプ別
    • アジア地域 特殊医薬品 市場規模:タイプ別 (2018-2023)
    • アジア地域 特殊医薬品 市場規模:タイプ別 (2024-2029)
    • アジア地域 特殊医薬品の市場シェア:タイプ別 (2018-2029)
  • アジア地域 特殊医薬品 市場規模:用途別
    • アジア地域 特殊医薬品 市場規模:用途別 (2018-2023)
    • アジア地域 特殊医薬品 市場規模:用途別 (2024-2029)
    • アジア地域 特殊医薬品の市場シェア:用途別 (2018-2029)
  • アジア地域 特殊医薬品 市場規模:地域別
    • アジア地域 特殊医薬品 市場規模:地域別: 2018 VS 2022 VS 2029
    • アジア地域 特殊医薬品 市場規模:地域別 (2018-2023)
    • アジア地域 特殊医薬品 市場規模:地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 特殊医薬品 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 特殊医薬品 市場規模:タイプ別
    • 中近東・アフリカ・中南米 特殊医薬品 市場規模:タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 特殊医薬品 市場規模:タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 特殊医薬品の市場シェア:タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 特殊医薬品 市場規模:用途別
    • 中近東・アフリカ・中南米 特殊医薬品 市場規模:用途別 (2018-2023)
    • 中近東・アフリカ・中南米 特殊医薬品 市場規模:用途別 (2024-2029)
    • 中近東・アフリカ・中南米 特殊医薬品の市場シェア:用途別 (2018-2029)
  • 中近東・アフリカ・中南米 特殊医薬品 市場規模:国別
    • 中近東・アフリカ・中南米 特殊医薬品 市場規模:国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 特殊医薬品 市場規模:国別 (2018-2023)
    • 中近東・アフリカ・中南米 特殊医薬品 市場規模:国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Pfizer
  • Roche
  • Amgen
  • AbbVie
  • Novo Nordisk
  • Johnson & Johnson
  • Sanofi-Aventis
  • Merck
  • Eli Lilly
  • Novartis
  • 3sbio
  • Changchun High Tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
  • Innovent

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Specialty Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Antibody
  • Table 3. Key Players of Hormone
  • Table 4. Key Players of Growth Factors
  • Table 5. Key Players of Other
  • Table 6. Global Specialty Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 7. Global Specialty Pharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 8. Global Specialty Pharmaceutical Market Size by Region (2018-2023) & (US$ Million)
  • Table 9. Global Specialty Pharmaceutical Market Share by Region (2018-2023)
  • Table 10. Global Specialty Pharmaceutical Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 11. Global Specialty Pharmaceutical Market Share by Region (2024-2029)
  • Table 12. Specialty Pharmaceutical Market Trends
  • Table 13. Specialty Pharmaceutical Market Drivers
  • Table 14. Specialty Pharmaceutical Market Challenges
  • Table 15. Specialty Pharmaceutical Market Restraints
  • Table 16. Global Specialty Pharmaceutical Revenue by Players (2018-2023) & (US$ Million)
  • Table 17. Global Specialty Pharmaceutical Revenue Share by Players (2018-2023)
  • Table 18. Global Top Specialty Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Pharmaceutical as of 2022)
  • Table 19. Global Specialty Pharmaceutical Industry Ranking 2021 VS 2022 VS 2023
  • Table 20. Global 5 Largest Players Market Share by Specialty Pharmaceutical Revenue (CR5 and HHI) & (2018-2023)
  • Table 21. Global Key Players of Specialty Pharmaceutical, Headquarters and Area Served
  • Table 22. Global Key Players of Specialty Pharmaceutical, Product and Application
  • Table 23. Global Key Players of Specialty Pharmaceutical, Product and Application
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Specialty Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
  • Table 26. Global Specialty Pharmaceutical Revenue Market Share by Type (2018-2023)
  • Table 27. Global Specialty Pharmaceutical Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 28. Global Specialty Pharmaceutical Revenue Market Share by Type (2024-2029)
  • Table 29. Global Specialty Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
  • Table 30. Global Specialty Pharmaceutical Revenue Share by Application (2018-2023)
  • Table 31. Global Specialty Pharmaceutical Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 32. Global Specialty Pharmaceutical Revenue Share by Application (2024-2029)
  • Table 33. North America Specialty Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
  • Table 34. North America Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
  • Table 35. North America Specialty Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
  • Table 36. North America Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
  • Table 37. North America Specialty Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 38. North America Specialty Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
  • Table 39. North America Specialty Pharmaceutical Market Size by Country (2024-2029) & (US$ Million)
  • Table 40. Europe Specialty Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
  • Table 41. Europe Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
  • Table 42. Europe Specialty Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
  • Table 43. Europe Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
  • Table 44. Europe Specialty Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 45. Europe Specialty Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
  • Table 46. Europe Specialty Pharmaceutical Market Size by Country (2024-2029) & (US$ Million)
  • Table 47. China Specialty Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
  • Table 48. China Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
  • Table 49. China Specialty Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
  • Table 50. China Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
  • Table 51. Asia Specialty Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
  • Table 52. Asia Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
  • Table 53. Asia Specialty Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
  • Table 54. Asia Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
  • Table 55. Asia Specialty Pharmaceutical Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 56. Asia Specialty Pharmaceutical Market Size by Region (2018-2023) & (US$ Million)
  • Table 57. Asia Specialty Pharmaceutical Market Size by Region (2024-2029) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Specialty Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 63. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
  • Table 64. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2024-2029) & (US$ Million)
  • Table 65. Pfizer Company Details
  • Table 66. Pfizer Business Overview
  • Table 67. Pfizer Specialty Pharmaceutical Product
  • Table 68. Pfizer Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 69. Pfizer Recent Developments
  • Table 70. Roche Company Details
  • Table 71. Roche Business Overview
  • Table 72. Roche Specialty Pharmaceutical Product
  • Table 73. Roche Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 74. Roche Recent Developments
  • Table 75. Amgen Company Details
  • Table 76. Amgen Business Overview
  • Table 77. Amgen Specialty Pharmaceutical Product
  • Table 78. Amgen Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 79. Amgen Recent Developments
  • Table 80. AbbVie Company Details
  • Table 81. AbbVie Business Overview
  • Table 82. AbbVie Specialty Pharmaceutical Product
  • Table 83. AbbVie Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 84. AbbVie Recent Developments
  • Table 85. Novo Nordisk Company Details
  • Table 86. Novo Nordisk Business Overview
  • Table 87. Novo Nordisk Specialty Pharmaceutical Product
  • Table 88. Novo Nordisk Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 89. Novo Nordisk Recent Developments
  • Table 90. Johnson & Johnson Company Details
  • Table 91. Johnson & Johnson Business Overview
  • Table 92. Johnson & Johnson Specialty Pharmaceutical Product
  • Table 93. Johnson & Johnson Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 94. Johnson & Johnson Recent Developments
  • Table 95. Sanofi-Aventis Company Details
  • Table 96. Sanofi-Aventis Business Overview
  • Table 97. Sanofi-Aventis Specialty Pharmaceutical Product
  • Table 98. Sanofi-Aventis Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 99. Sanofi-Aventis Recent Developments
  • Table 100. Merck Company Details
  • Table 101. Merck Business Overview
  • Table 102. Merck Specialty Pharmaceutical Product
  • Table 103. Merck Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 104. Merck Recent Developments
  • Table 105. Eli Lilly Company Details
  • Table 106. Eli Lilly Business Overview
  • Table 107. Eli Lilly Specialty Pharmaceutical Product
  • Table 108. Eli Lilly Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 109. Eli Lilly Recent Developments
  • Table 110. Novartis Company Details
  • Table 111. Novartis Business Overview
  • Table 112. Novartis Specialty Pharmaceutical Product
  • Table 113. Novartis Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 114. Novartis Recent Developments
  • Table 115. 3sbio Company Details
  • Table 116. 3sbio Business Overview
  • Table 117. 3sbio Specialty Pharmaceutical Product
  • Table 118. 3sbio Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 119. 3sbio Recent Developments
  • Table 120. Changchun High Tech Company Details
  • Table 121. Changchun High Tech Business Overview
  • Table 122. Changchun High Tech Specialty Pharmaceutical Product
  • Table 123. Changchun High Tech Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 124. Changchun High Tech Recent Developments
  • Table 125. CP Guojian Pharmacy Company Details
  • Table 126. CP Guojian Pharmacy Business Overview
  • Table 127. CP Guojian Pharmacy Specialty Pharmaceutical Product
  • Table 128. CP Guojian Pharmacy Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 129. CP Guojian Pharmacy Recent Developments
  • Table 130. Biotech Pharma Company Details
  • Table 131. Biotech Pharma Business Overview
  • Table 132. Biotech Pharma Specialty Pharmaceutical Product
  • Table 133. Biotech Pharma Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 134. Biotech Pharma Recent Developments
  • Table 135. Gelgen Biopharma Company Details
  • Table 136. Gelgen Biopharma Business Overview
  • Table 137. Gelgen Biopharma Specialty Pharmaceutical Product
  • Table 138. Gelgen Biopharma Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 139. Gelgen Biopharma Recent Developments
  • Table 140. Innovent Company Details
  • Table 141. Innovent Business Overview
  • Table 142. Innovent Specialty Pharmaceutical Product
  • Table 143. Innovent Revenue in Specialty Pharmaceutical Business (2018-2023) & (US$ Million)
  • Table 144. Innovent Recent Developments
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Specialty Pharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Specialty Pharmaceutical Market Share by Type: 2022 VS 2029
  • Figure 3. Antibody Features
  • Figure 4. Hormone Features
  • Figure 5. Growth Factors Features
  • Figure 6. Other Features
  • Figure 7. Global Specialty Pharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global Specialty Pharmaceutical Market Share by Application: 2022 VS 2029
  • Figure 9. Tumor Case Studies
  • Figure 10. Diabetes Case Studies
  • Figure 11. Cardiovascular Case Studies
  • Figure 12. Hemophilia Case Studies
  • Figure 13. Other Case Studies
  • Figure 14. Specialty Pharmaceutical Report Years Considered
  • Figure 15. Global Specialty Pharmaceutical Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 16. Global Specialty Pharmaceutical Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 17. Global Specialty Pharmaceutical Market Share by Region: 2022 VS 2029
  • Figure 18. Global Specialty Pharmaceutical Market Share by Players in 2022
  • Figure 19. Global Top Specialty Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Pharmaceutical as of 2022)
  • Figure 20. The Top 10 and 5 Players Market Share by Specialty Pharmaceutical Revenue in 2022
  • Figure 21. North America Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. North America Specialty Pharmaceutical Market Share by Type (2018-2029)
  • Figure 23. North America Specialty Pharmaceutical Market Share by Application (2018-2029)
  • Figure 24. North America Specialty Pharmaceutical Market Share by Country (2018-2029)
  • Figure 25. United States Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Canada Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. Europe Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
  • Figure 28. Europe Specialty Pharmaceutical Market Share by Type (2018-2029)
  • Figure 29. Europe Specialty Pharmaceutical Market Share by Application (2018-2029)
  • Figure 30. Europe Specialty Pharmaceutical Market Share by Country (2018-2029)
  • Figure 31. Germany Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. France Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. U.K. Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Italy Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Russia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. Nordic Countries Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 37. China Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
  • Figure 38. China Specialty Pharmaceutical Market Share by Type (2018-2029)
  • Figure 39. China Specialty Pharmaceutical Market Share by Application (2018-2029)
  • Figure 40. Asia Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
  • Figure 41. Asia Specialty Pharmaceutical Market Share by Type (2018-2029)
  • Figure 42. Asia Specialty Pharmaceutical Market Share by Application (2018-2029)
  • Figure 43. Asia Specialty Pharmaceutical Market Share by Region (2018-2029)
  • Figure 44. Japan Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. South Korea Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. China Taiwan Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Southeast Asia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. India Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. Australia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 50. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
  • Figure 51. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Type (2018-2029)
  • Figure 52. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Application (2018-2029)
  • Figure 53. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Country (2018-2029)
  • Figure 54. Brazil Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Mexico Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Turkey Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Saudi Arabia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. Israel Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 59. GCC Countries Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 60. Pfizer Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 61. Roche Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 62. Amgen Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 63. AbbVie Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 64. Novo Nordisk Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 65. Johnson & Johnson Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 66. Sanofi-Aventis Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 67. Merck Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 68. Eli Lilly Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 69. Novartis Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 70. 3sbio Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 71. Changchun High Tech Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 72. CP Guojian Pharmacy Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 73. Biotech Pharma Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 74. Gelgen Biopharma Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 75. Innovent Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2023)
  • Figure 76. Bottom-up and Top-down Approaches for This Report
  • Figure 77. Data Triangulation
  • Figure 78. Key Executives Interviewed
目次

This research report focuses on the Specialty Pharmaceutical Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Specialty Pharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Antibody
    • 1.2.3 Hormone
    • 1.2.4 Growth Factors
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Specialty Pharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Tumor
    • 1.3.3 Diabetes
    • 1.3.4 Cardiovascular
    • 1.3.5 Hemophilia
    • 1.3.6 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Specialty Pharmaceutical Market Perspective (2018-2029)
  • 2.2 Global Specialty Pharmaceutical Growth Trends by Region
    • 2.2.1 Specialty Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Specialty Pharmaceutical Historic Market Size by Region (2018-2023)
    • 2.2.3 Specialty Pharmaceutical Forecasted Market Size by Region (2024-2029)
  • 2.3 Specialty Pharmaceutical Market Dynamics
    • 2.3.1 Specialty Pharmaceutical Industry Trends
    • 2.3.2 Specialty Pharmaceutical Market Drivers
    • 2.3.3 Specialty Pharmaceutical Market Challenges
    • 2.3.4 Specialty Pharmaceutical Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Specialty Pharmaceutical by Players
    • 3.1.1 Global Specialty Pharmaceutical Revenue by Players (2018-2023)
    • 3.1.2 Global Specialty Pharmaceutical Revenue Market Share by Players (2018-2023)
  • 3.2 Global Specialty Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Specialty Pharmaceutical, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Specialty Pharmaceutical Market Concentration Ratio
    • 3.4.1 Global Specialty Pharmaceutical Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Specialty Pharmaceutical Revenue in 2022
  • 3.5 Global Key Players of Specialty Pharmaceutical Head office and Area Served
  • 3.6 Global Key Players of Specialty Pharmaceutical, Product and Application
  • 3.7 Global Key Players of Specialty Pharmaceutical, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Specialty Pharmaceutical Breakdown Data by Type

  • 4.1 Global Specialty Pharmaceutical Historic Market Size by Type (2018-2023)
  • 4.2 Global Specialty Pharmaceutical Forecasted Market Size by Type (2024-2029)

5 Specialty Pharmaceutical Breakdown Data by Application

  • 5.1 Global Specialty Pharmaceutical Historic Market Size by Application (2018-2023)
  • 5.2 Global Specialty Pharmaceutical Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Specialty Pharmaceutical Market Size (2018-2029)
  • 6.2 North America Specialty Pharmaceutical Market Size by Type
    • 6.2.1 North America Specialty Pharmaceutical Market Size by Type (2018-2023)
    • 6.2.2 North America Specialty Pharmaceutical Market Size by Type (2024-2029)
    • 6.2.3 North America Specialty Pharmaceutical Market Share by Type (2018-2029)
  • 6.3 North America Specialty Pharmaceutical Market Size by Application
    • 6.3.1 North America Specialty Pharmaceutical Market Size by Application (2018-2023)
    • 6.3.2 North America Specialty Pharmaceutical Market Size by Application (2024-2029)
    • 6.3.3 North America Specialty Pharmaceutical Market Share by Application (2018-2029)
  • 6.4 North America Specialty Pharmaceutical Market Size by Country
    • 6.4.1 North America Specialty Pharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Specialty Pharmaceutical Market Size by Country (2018-2023)
    • 6.4.3 North America Specialty Pharmaceutical Market Size by Country (2024-2029)
    • 6.4.4 the United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Specialty Pharmaceutical Market Size (2018-2029)
  • 7.2 Europe Specialty Pharmaceutical Market Size by Type
    • 7.2.1 Europe Specialty Pharmaceutical Market Size by Type (2018-2023)
    • 7.2.2 Europe Specialty Pharmaceutical Market Size by Type (2024-2029)
    • 7.2.3 Europe Specialty Pharmaceutical Market Share by Type (2018-2029)
  • 7.3 Europe Specialty Pharmaceutical Market Size by Application
    • 7.3.1 Europe Specialty Pharmaceutical Market Size by Application (2018-2023)
    • 7.3.2 Europe Specialty Pharmaceutical Market Size by Application (2024-2029)
    • 7.3.3 Europe Specialty Pharmaceutical Market Share by Application (2018-2029)
  • 7.4 Europe Specialty Pharmaceutical Market Size by Country
    • 7.4.1 Europe Specialty Pharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Specialty Pharmaceutical Market Size by Country (2018-2023)
    • 7.4.3 Europe Specialty Pharmaceutical Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Specialty Pharmaceutical Market Size (2018-2029)
  • 8.2 China Specialty Pharmaceutical Market Size by Type
    • 8.2.1 China Specialty Pharmaceutical Market Size by Type (2018-2023)
    • 8.2.2 China Specialty Pharmaceutical Market Size by Type (2024-2029)
    • 8.2.3 China Specialty Pharmaceutical Market Share by Type (2018-2029)
  • 8.3 China Specialty Pharmaceutical Market Size by Application
    • 8.3.1 China Specialty Pharmaceutical Market Size by Application (2018-2023)
    • 8.3.2 China Specialty Pharmaceutical Market Size by Application (2024-2029)
    • 8.3.3 China Specialty Pharmaceutical Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Specialty Pharmaceutical Market Size (2018-2029)
  • 9.2 Asia Specialty Pharmaceutical Market Size by Type
    • 9.2.1 Asia Specialty Pharmaceutical Market Size by Type (2018-2023)
    • 9.2.2 Asia Specialty Pharmaceutical Market Size by Type (2024-2029)
    • 9.2.3 Asia Specialty Pharmaceutical Market Share by Type (2018-2029)
  • 9.3 Asia Specialty Pharmaceutical Market Size by Application
    • 9.3.1 Asia Specialty Pharmaceutical Market Size by Application (2018-2023)
    • 9.3.2 Asia Specialty Pharmaceutical Market Size by Application (2024-2029)
    • 9.3.3 Asia Specialty Pharmaceutical Market Share by Application (2018-2029)
  • 9.4 Asia Specialty Pharmaceutical Market Size by Region
    • 9.4.1 Asia Specialty Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Specialty Pharmaceutical Market Size by Region (2018-2023)
    • 9.4.3 Asia Specialty Pharmaceutical Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Details
    • 11.1.2 Pfizer Business Overview
    • 11.1.3 Pfizer Specialty Pharmaceutical Introduction
    • 11.1.4 Pfizer Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.1.5 Pfizer Recent Developments
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Specialty Pharmaceutical Introduction
    • 11.2.4 Roche Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.2.5 Roche Recent Developments
  • 11.3 Amgen
    • 11.3.1 Amgen Company Details
    • 11.3.2 Amgen Business Overview
    • 11.3.3 Amgen Specialty Pharmaceutical Introduction
    • 11.3.4 Amgen Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.3.5 Amgen Recent Developments
  • 11.4 AbbVie
    • 11.4.1 AbbVie Company Details
    • 11.4.2 AbbVie Business Overview
    • 11.4.3 AbbVie Specialty Pharmaceutical Introduction
    • 11.4.4 AbbVie Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.4.5 AbbVie Recent Developments
  • 11.5 Novo Nordisk
    • 11.5.1 Novo Nordisk Company Details
    • 11.5.2 Novo Nordisk Business Overview
    • 11.5.3 Novo Nordisk Specialty Pharmaceutical Introduction
    • 11.5.4 Novo Nordisk Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.5.5 Novo Nordisk Recent Developments
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Company Details
    • 11.6.2 Johnson & Johnson Business Overview
    • 11.6.3 Johnson & Johnson Specialty Pharmaceutical Introduction
    • 11.6.4 Johnson & Johnson Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.6.5 Johnson & Johnson Recent Developments
  • 11.7 Sanofi-Aventis
    • 11.7.1 Sanofi-Aventis Company Details
    • 11.7.2 Sanofi-Aventis Business Overview
    • 11.7.3 Sanofi-Aventis Specialty Pharmaceutical Introduction
    • 11.7.4 Sanofi-Aventis Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.7.5 Sanofi-Aventis Recent Developments
  • 11.8 Merck
    • 11.8.1 Merck Company Details
    • 11.8.2 Merck Business Overview
    • 11.8.3 Merck Specialty Pharmaceutical Introduction
    • 11.8.4 Merck Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.8.5 Merck Recent Developments
  • 11.9 Eli Lilly
    • 11.9.1 Eli Lilly Company Details
    • 11.9.2 Eli Lilly Business Overview
    • 11.9.3 Eli Lilly Specialty Pharmaceutical Introduction
    • 11.9.4 Eli Lilly Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.9.5 Eli Lilly Recent Developments
  • 11.10 Novartis
    • 11.10.1 Novartis Company Details
    • 11.10.2 Novartis Business Overview
    • 11.10.3 Novartis Specialty Pharmaceutical Introduction
    • 11.10.4 Novartis Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.10.5 Novartis Recent Developments
  • 11.11 3sbio
    • 11.11.1 3sbio Company Details
    • 11.11.2 3sbio Business Overview
    • 11.11.3 3sbio Specialty Pharmaceutical Introduction
    • 11.11.4 3sbio Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.11.5 3sbio Recent Developments
  • 11.12 Changchun High Tech
    • 11.12.1 Changchun High Tech Company Details
    • 11.12.2 Changchun High Tech Business Overview
    • 11.12.3 Changchun High Tech Specialty Pharmaceutical Introduction
    • 11.12.4 Changchun High Tech Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.12.5 Changchun High Tech Recent Developments
  • 11.13 CP Guojian Pharmacy
    • 11.13.1 CP Guojian Pharmacy Company Details
    • 11.13.2 CP Guojian Pharmacy Business Overview
    • 11.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Introduction
    • 11.13.4 CP Guojian Pharmacy Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.13.5 CP Guojian Pharmacy Recent Developments
  • 11.14 Biotech Pharma
    • 11.14.1 Biotech Pharma Company Details
    • 11.14.2 Biotech Pharma Business Overview
    • 11.14.3 Biotech Pharma Specialty Pharmaceutical Introduction
    • 11.14.4 Biotech Pharma Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.14.5 Biotech Pharma Recent Developments
  • 11.15 Gelgen Biopharma
    • 11.15.1 Gelgen Biopharma Company Details
    • 11.15.2 Gelgen Biopharma Business Overview
    • 11.15.3 Gelgen Biopharma Specialty Pharmaceutical Introduction
    • 11.15.4 Gelgen Biopharma Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.15.5 Gelgen Biopharma Recent Developments
  • 11.16 Innovent
    • 11.16.1 Innovent Company Details
    • 11.16.2 Innovent Business Overview
    • 11.16.3 Innovent Specialty Pharmaceutical Introduction
    • 11.16.4 Innovent Revenue in Specialty Pharmaceutical Business (2018-2023)
    • 11.16.5 Innovent Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details